Can Chinese Phase I data from the West accelerate China drug development?
The science of ethnobridging – a way to implement cost-effective, multi-ethnic approaches to global clinical trial research and drug development.
Related Insights
Video
The science and practice of ethnobridging
May 17, 2023
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Blog
Six steps to maximize inclusivity within medical communications | Part 1: Race and Ethnicity
Mar 3, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Related Insights
Video
The science and practice of ethnobridging
May 17, 2023
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Article
Australia: A highly attractive environment for drug development
Aug 24, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Blog
Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients
Sep 23, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Blog
Six steps to maximize inclusivity within medical communications | Part 1: Race and Ethnicity
Mar 3, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021